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2070REPLY: Prognostic Role of CMR Imaging
After Myocardial InfarctionWe thank Drs. Eitel and Thiele for the interest in our
work (1). They highlight some possible limitations of
our approach on several points that merit discussion.
Cardiovascular magnetic resonance imaging (CMR)
is a continuously evolving technique, which leads to
new opportunities and the expansion of indications.
In our systematic review, we summarized all pub-
lished papers regarding the prognostic value of CMR
ﬁndings in patients with a recent myocardial infarc-
tion (MI) or suspected or known coronary artery
disease.
As mentioned in our study, if the CMR ﬁnding was
studied in <1,000 patients, it was classiﬁed as “not
enough evidence to make inference about its prog-
nostic value” (1). Although this value is arbitrarily
chosen, lowering this threshold would lead to more
CMR ﬁndings incorrectly being classiﬁed as an
independent prognostic marker. In the majority of
studies, the number of events/variable in multi-
variable analyses was less than 10, leading to a
possible overestimation or underestimation of the
reported hazard ratios in those studies (2). Although
there is no established threshold, we considered the
value of 1,000 patients to be appropriate.
We concluded that none of the CMR ﬁndings,
including left ventricular ejection fraction (LVEF),
was studied in more than 1,000 patients with an MI,
and therefore no inferences could be made about its
independent prognostic value to predict hard clinical
events. The prognostic value of late microvascular
obstruction (MVO) was assessed in 2 papers, in-
cluding 624 patients, and 1 of the studies showed a
signiﬁcant result.
We found that LVEF is an independent prognostic
CMR ﬁnding to predict major adverse cardiovascular
events in patients with a recent MI. As for late MVO,
all 3 studies including 668 patients showed a signiﬁ-
cant result. This shows that late MVO is a promising
CMR ﬁnding to predict future events but is not
studied in enough patients yet. Due to the difference
between studies in CMR ﬁndings included in the
multivariable analyses, we were not able to directly
compare the prognostic value of the CMR ﬁndings.
Therefore, we can conclude that LVEF is an inde-
pendent CMR ﬁnding, but its relative value withrespect to (other) CMR ﬁndings, such as late MVO,
could not be studied.
We agree that heterogeneity in reporting and sta-
tistical analyses is an important limitation of the re-
sults presented in systematic reviews. We therefore
could not aggregate the results of the individual
studies. As discussed in our paper (1) and the
associated editorial (3), a large individual patient
data meta-analysis can provide more information on
the relative prognostic value of CMR ﬁndings.
We recently started the PROMISE collaboration (4)
to collect data from published studies assessing
the prognostic value of CMR. By analyzing data
from previously published studies that might be
underpowered themselves on the patient level and
by accounting for differences in patient and study
characteristics, the incremental value of the CMR
ﬁndings, in addition to already known risk factors,
can be assessed. In this way, readily available data
can be used, and it might not be necessary to spend
costly resources to perform multicenter studies that
require a large number of patients and long-term
follow-up, as suggested by Drs. Eitel and Thiele.*Hamza El Aidi, MD
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